Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05412953 · ClinicalTrials.gov registry record · NA

Tonation Breathing Technique Method to Ease Aromatase Inhibitor-induced Joint and/or Muscle Pain

A NA study, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
15
Enrollment target

NCT05412953: Completed NA study, sponsored by Mayo Clinic.

NCT05412953 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT05412953, a NA study, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target

Study Summary

This clinical trial evaluates how well tonation breathing techniques (use of a breathing and tonation \[creating sounds\]) works to ease pain joint and/or muscle pain in patients with stage I-III breast cancer and currently take an aromatase inhibitor. Tonation breathing techniques may help relieve pain in patients with stage I-III breast cancer who are receiving aromatase inhibitor.

Primary Outcome

Patients will be asked to complete a validated brief pain inventory- SF ( BPI-SF) at baseline and after 2 weeks which would be end of study. The BPI- SF measures pain intensity at its worse in the last week, at its least in the last week in addition to average pain and location of pain. It also measures relief of pain from pain treatments or medications and percentage of relief.

Interventions

  • OTHER Questionnaire Administration
  • BEHAVIORAL Tonation Breathing Technique

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2022-02-22
Est. Completion 2024-06-27
Phase NA
Mayo Clinic

2,844 total trials

What the finished NCT05412953 record still lists

NCT05412953 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which Questionnaire Administration is the first listed.

NCT05412953 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05412953 about?

NCT05412953 is a clinical study titled "Tonation Breathing Technique Method to Ease Aromatase Inhibitor-induced Joint and/or Muscle Pain". This clinical trial evaluates how well tonation breathing techniques (use of a breathing and tonation \[creating sounds\]) works to ease pain joint and/or muscle pain in patients with stage I-III breast cancer and currently take an aromatase inhibitor. Tonation breathing techniques may help relieve ...

What is the current status of trial NCT05412953?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2022-02-22. Estimated completion is 2024-06-27.

What interventions are being tested in trial NCT05412953?

The interventions under investigation include: Questionnaire Administration (OTHER), Tonation Breathing Technique (BEHAVIORAL).

Who is sponsoring clinical trial NCT05412953?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05412953's enrollment target sits among peer trials

15 1881st of 2000 higher than 92 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01889381 · 15 participants · Phase 2

    Human Craniomaxillofacial Allotransplantation

  • NCT02530073 · 15 participants · NA

    Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

  • NCT02535936 · 15 participants · NA

    Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy

  • NCT02918474 · 15 participants · NA

    Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05412953, the US trial registry maintained by the National Library of Medicine. NCT05412953 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.